Thermo Fisher Scientific (TMO) Total Liabilities (2009 - 2026)

Thermo Fisher Scientific has disclosed Total Liabilities across 18 years of filings, most recently posting $61.3 billion for Q1 2026.

• Quarterly Total Liabilities rose 23.47% year-over-year to $61.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $61.3 billion (up 23.47% YoY) and the FY2025 annual result came in at $56.9 billion, up 19.19% from the prior year.
• Total Liabilities advanced to $61.3 billion in Q1 2026, from $56.9 billion in the prior quarter.
• Over five years, Total Liabilities peaked at $61.3 billion in Q1 2026 and troughed at $46.9 billion in Q4 2022.
• A 5-year average of $51.7 billion and a median of $51.6 billion in 2024 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities jumped 67.61% — and 2024, when it fell 8.14%.
• Tracing TMO's Total Liabilities over 5 years: stood at $53.1 billion in 2022, then fell by 2.11% to $52.0 billion in 2023, then slipped by 8.14% to $47.8 billion in 2024, then rose by 19.19% to $56.9 billion in 2025, then grew by 7.75% to $61.3 billion in 2026.
• Business Quant data shows TMO's Total Liabilities at $61.3 billion in Q1 2026, $56.9 billion in Q4 2025, and $52.0 billion in Q3 2025.